A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial
Titel:
A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial
Auteur:
Bertrand, Olivier F. Poirier, Paul Rodés-Cabau, Josep Rinfret, Stéphane Title, Lawrence Dzavik, Vladimir Natarajan, Madhu Angel, Juan Batalla, Nuria Alméras, Natalie Costerousse, Olivier De Larochellière, Robert Roy, Louis Després, Jean-Pierre